12.26

6.15% 0.71

Pre-market: 13.55 1.29 +10.52%

Hyperion Defi Inc (HYPD)

Overview News Price History Discussions Forecast

Hyperion Defi Inc stock is traded at $12.26, with a volume of 1.48M. It is up +6.15% in the last 24 hours and up +70.28% over the past month. Hyperion DeFi Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.

Previous Close:

$11.55

Open:

$11.91

24h Volume:

1.48M

Relative Volume:

2.59

Market Cap:

$69.82M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+15.66%

1M Performance:

+70.28%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$11.30

$12.91

1-Week Range:

$10.04

$15.00

52-Week Range:

$5.075

$16.12

Hyperion Defi Inc Stock (HYPD) Company Profile

Name

Hyperion Defi Inc

Sector

Healthcare (1145)

Industry

Biotechnology (643)

Phone

813-766-9539

Address

295 MADISON AVENUE,, NEW YORK

Employee

Twitter

Next Earnings Date

Latest SEC Filings

HYPD's Discussions on Twitter

Compare HYPD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYPD Hyperion Defi Inc	12.26	65.77M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	387.15	100.34B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	585.50	60.95B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	451.73	60.46B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	734.35	46.04B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	332.20	36.02B	3.81B	-644.79M	-669.77M	-6.24

Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-24	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-01-21	Initiated	Northland Capital	Outperform
Feb-03-20	Downgrade	Oppenheimer	Outperform → Perform

Hyperion Defi Inc Stock (HYPD) Latest News

Sep 16, 2025

Hyperion DeFi signs first HYPE asset use agreement with Credo Cayman - Investing.com

Sep 16, 2025

Hyperion DeFi enters into first HAUS agreement with proprietary trading firm Credo - MarketScreener

Sep 16, 2025

Hyperion DeFi, Inc. Announces Groundbreaking HYPE Asset Use Service Agreement with Credo Cayman - Quiver Quantitative

Sep 16, 2025

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo - 富途牛牛

Sep 16, 2025

Sep 11, 2025

Hyperion DeFi announces CEO change, appoints interim leader By Investing.com - Investing.com Australia

Sep 10, 2025

Sep 09, 2025

Hyperion DeFi Stock Jumps As Retail Traders Back CEO Shake-Up - Asianet Newsable

Sep 09, 2025

Hyperion DeFi, Inc. Announces Board Changes - MarketScreener

Sep 09, 2025

Hyperion DeFi announces CEO change, appoints interim leader - Investing.com

Sep 09, 2025

Hyperion DeFi strengthens leadership team with key appointments to accelerate DeFi strategy - MarketScreener

Sep 09, 2025

Hyperion DeFi Strengthens Leadership Team With Key Appointments to Accelerate DeFi Strategy - MarketScreener

Sep 09, 2025

Major Leadership Shake-up: Hyperion DeFi Appoints New Interim CEO and Blockchain Veteran to Board - Stock Titan

Sep 09, 2025

Sep 08, 2025

Hyperion DeFi regains Nasdaq compliance, appoints new board member - Investing.com

Sep 08, 2025

Aug 27, 2025